<DOC>
	<DOC>NCT01301781</DOC>
	<brief_summary>A pilot study to evaluate the safety and efficacy of BLI801 vs. placebo in constipated adults.</brief_summary>
	<brief_title>BLI801 Laxative in Constipated Adults</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Cathartics</mesh_term>
	<criteria>Constipated, defined by ROME III definition Subject has &lt; 3 satisfactory BMs during the runin period Subjects with known or suspected ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon Subjects taking laxatives or prokinetic agents that refuse to discontinue these treatments. Subjects who are allergic to any BLI801 component Subjects taking narcotic analgesics or other medications known to cause constipation. Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures Subjects who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days Subjects with an active history of drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>